Hydrogenics Corp (NASDAQ:HYGS)‘s stock had its “buy” rating reaffirmed by stock analysts at Ascendiant Capital Markets in a report issued on Friday, AmericanBankingNews.com reports. They currently have a $33.00 price target on the stock. Ascendiant Capital Markets’ price target indicates a potential upside of 27.27% from the company’s current price. Hydrogenics Corporation (USA) (NASDAQ:HYGS) shares after opening at $27.46 moved to $27.95 on last trade day and at the end of the day closed at $27.94. Company price to sales ratio in past twelve months was calculated as 5.93 and price to cash ratio as 21.32. Hydrogenics Corporation (USA) (NASDAQ:HYGS) showed a positive weekly performance of 2.31%.
On March 28, 2014, Comstock Holding Companies, Inc. (NASDAQ:CHCI) issued a press release announcing its results for the three months and twelve months ended December 31, 2013. Comstock Holding Companies Inc. (NASDAQ:CHCI) shares fell -4.09% in last trading session and ended the day on $1.72. CHCI return on equity ratio is recorded as -50.70% and its return on assets is -6.50%. Comstock Holding Companies Inc. (NASDAQ:CHCI) yearly performance is -2.45%.
Investors in UQM Technologies, Inc. (NYSEMKT:UQM) saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the UQM options chain for the new May 17th contracts. UQM Technologies Inc. (NYSEMKT:UQM) shares moved down -3.82% in last trading session and was closed at $2.52, while trading in range of $2.38 – $2.64. UQM Technologies Inc. (NYSEMKT:UQM) year to date (YTD) performance is 17.76%.
On March 26, 2014, Installed Building Products, Inc. (NYSE:IBP) issued a press release reporting the financial results for the three months and full year ended December 31, 2013. Installed Building Products Inc. (NYSE:IBP) weekly performance is -2.89%. On last trading day company shares ended up $13.11. Installed Building Products Inc. (NYSE:IBP) distance from 50-day simple moving average (SMA50) is -5.35%. Analysts mean target price for the company is $18.00.